Holen Sie sich die Stockscreener-App
0.93
2.52%
-0.024
Handel nachbörslich:
.93
Nanovibronix Inc Aktie (NAOV) Neueste Nachrichten
NAOV’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
3 Penny Stocks to Watch Now, 6/12/25 - TipRanks
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Gui - GuruFocus
NanoVibronix (NAOV) Secures U.S. Patent for Pediatric Feeding Tu - GuruFocus
NanoVibronix receives U.S. patent for pediatric feeding tube system By Investing.com - Investing.com Canada
NanoVibronix Stock Soars: Why This Tiny Medical Tech Is Making Big Waves Today - RagingBull
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
NanoVibronix receives U.S. patent for pediatric feeding tube system - Investing.com
Revolutionary Patent: ENvue Medical Targets 1.5M Annual Pediatric Procedures with Smart Feeding Tube Technology - Stock Titan
NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’ - MSN
NanoVibronix appoints new CEO after acquisition By Investing.com - Investing.com India
NanoVibronix Appoints Doron Besser as New CEO - TipRanks
NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’ By Stocktwits - Investing.com India
NanoVibronix Appoints Doron Besser as CEO - citybiz
NanoVibronix, Inc Announces CEO Changes, Effective June 4, 2025 - marketscreener.com
NanoVibronix Has a Leadership Transition - Medical Product Outsourcing
NanoVibronix (NAOV) Appoints New CEO as Leadership Changes Unfol - GuruFocus
NanoVibronix appoints new CEO after acquisition - Investing.com Australia
NanoVibronix Announces CEO Transition | NAOV Stock News - GuruFocus
NanoVibronix Announces CEO Transition - Business Wire
NanoVibronix Shares Positive Results from UroShield Case Series - Medical Product Outsourcing
NanoVibronix refutes false stock offering claims By Investing.com - Investing.com South Africa
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
NanoVibronix says offering posts falsely issued by Flash Alert, FintelAlerts - TipRanks
NanoVibronix (NAOV) Denies $26M Stock Offering Rumors | NAOV Sto - GuruFocus
NanoVibronix Responds to False Post | NAOV Stock News - GuruFocus
NanoVibronix refutes false stock offering claims - Investing.com
NanoVibronix Responds to False Post - marketscreener.com
NanoVibronix Exposes False $26M Stock Offering Alert: Company Takes Action Against Misinformation - Stock Titan
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures | NAOV Stock News - GuruFocus
Major Louisiana Hospital Ditches Blind Insertions for Advanced ENvue Feeding Tube Technology - Stock Titan
Major Louisiana Hospital Selects ENvue System for Feeding Tube P - GuruFocus
NanoVibronix stock plunges to 52-week low at $1.14 By Investing.com - Investing.com South Africa
NanoVibronix stock plunges to 52-week low at $1.14 - Investing.com
NanoVibronix, Inc. SEC 10-Q Report - TradingView
NanoVibronix announces pricing of public offering - Medical Buyer
NanoVibronix announces pricing of $10 million public offering - MSN
NanoVibronix Announces Closing Of $10 Million Public Offering Of Preferred Stock And Warrants - marketscreener.com
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants - Business Wire
NanoVibronix (NAOV) Announces $10 Million Public Offering - GuruFocus
SEC Form 424B4 filed by NanoVibronix Inc. - Quantisnow
Nasdaq Top 5 Premarket Losers: Healthcare Triangle, Klotho Neurosciences, New Fortress Energy, NanoVibronix, MDJM - MSN
NanoVibronix sets terms for $10 million public offering By Investing.com - Investing.com Nigeria
NanoVibronix acquires enteral tech firm ENvue Medical - MSN
NanoVibronix Delays Q1 2025 Financial Report - TipRanks
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants | NAOV Stock News - GuruFocus
NanoVibronix sets terms for $10 million public offering - Investing.com
NanoVibronix Secures $10M Through Preferred Stock Sale: Strategic Move to Eliminate $2M in Recent Debt - Stock Titan
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):